Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



GOLDSTEIN DOV A MD Create: Alert

All | News | Filings
Date FiledTypeDescription
01/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
09/22/2022 4 GOLDSTEIN DOV A MD (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 10,500 options to buy @ $3.5, valued at $36.8k
09/12/2022 4 GOLDSTEIN DOV A MD (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 37,600 options to buy @ $0.6, valued at $22.6k
09/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/17/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
09/11/2020 4 GOLDSTEIN DOV A MD (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 14,634 options to buy @ $8.8, valued at $128.8k
05/04/2020 4 GOLDSTEIN DOV A MD (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Bought 10,000 shares @ $6, valued at $60k
05/01/2020 4/A GOLDSTEIN DOV A MD (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns: Granted 7,500 shares @ $0
03/03/2020 4 GOLDSTEIN DOV A MD (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns: Granted 7,500 shares @ $0
Granted 15,000 options to buy @ $2.915, valued at $43.7k
07/16/2019 4 GOLDSTEIN DOV A MD (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.
Txns: Granted 227,330 options to buy @ $5.39, valued at $1.2M
07/16/2019 3 GOLDSTEIN DOV A MD (Director) has filed a Form 3 on NeuBase Therapeutics, Inc.
03/15/2019 4 GOLDSTEIN DOV A MD (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns: Granted 30,000 options to buy @ $3.89, valued at $116.7k
06/25/2018 4 GOLDSTEIN DOV A MD (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns: Granted 17,500 options to buy @ $4.91, valued at $85.9k
06/08/2018 4 GOLDSTEIN DOV A MD (Director) has filed a Form 4 on Esperion Therapeutics, Inc.
Txns: Disposed of 5,000 shares @ $0
Disposed of 8,000 shares @ $0
Exercised 5,000 options to buy @ $14.42, valued at $72.1k
Exercised 8,000 options to buy @ $17.75, valued at $142k
05/25/2018 4 GOLDSTEIN DOV A MD (Director) has filed a Form 4 on Esperion Therapeutics, Inc.
Txns: Granted 10,100 options to buy @ $38.32, valued at $387k
12/20/2017 4 GOLDSTEIN DOV A MD (Director) has filed a Form 4 on Esperion Therapeutics, Inc.
Txns: Disposed of 21,471 shares @ $0
Exercised 21,471 options to buy @ $3.7, valued at $79.4k
12/08/2017 4 GOLDSTEIN DOV A MD (Director) has filed a Form 4 on Esperion Therapeutics, Inc.
Txns: Acquired 38 shares @ $0
06/08/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
04/19/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/23/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/09/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/16/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/16/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/18/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/10/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/09/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/25/2013 3 Form 3 - Initial statement of beneficial ownership of securities
07/25/2012 4 GOLDSTEIN DOV A MD (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.
04/05/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
03/23/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy